Oral contraceptives & breast cancer:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academy Press
1991
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index "At least 10.7 million American women use oral contraceptives (OCs). The potential connection with breast cancer has caused concern among these OC users and uncertainty among many of their physicians. This new volume offers the most up-to-date information available on this critical topic. While the best available knowledge does not support any fundamental change in clinical practice with respect to the use of OCs, this book offers specific recommendations for more research to fully resolve the relationship between OCs and breast cancer. Noting consumer confusion, the volume includes a concise summary of benefits, risks, and other practical information for contraceptive users and their doctors. The volume presents current data on changes in patterns of OC use, differences in risk at different ages, the benefits of OCs, and more."--Website description |
| Beschreibung: | 1 Online-Ressource (viii, 185 pages) |
| ISBN: | 0309044936 0585149011 9780309044936 9780585149011 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043070465 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s1991 |||| o||u| ||||||eng d | ||
| 020 | |a 0309044936 |9 0-309-04493-6 | ||
| 020 | |a 0585149011 |9 0-585-14901-1 | ||
| 020 | |a 9780309044936 |9 978-0-309-04493-6 | ||
| 020 | |a 9780585149011 |9 978-0-585-14901-1 | ||
| 035 | |a (OCoLC)43477116 | ||
| 035 | |a (DE-599)BVBBV043070465 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.99/449071 |2 20 | |
| 110 | 2 | |a Institute of Medicine (U.S.) |b Committee on the Relationship Between Oral Contraceptives and Breast Cancer |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Oral contraceptives & breast cancer |c Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
| 246 | 1 | 3 | |a Oral contraceptives and breast cancer |
| 264 | 1 | |a Washington, D.C. |b National Academy Press |c 1991 | |
| 300 | |a 1 Online-Ressource (viii, 185 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a "At least 10.7 million American women use oral contraceptives (OCs). The potential connection with breast cancer has caused concern among these OC users and uncertainty among many of their physicians. This new volume offers the most up-to-date information available on this critical topic. While the best available knowledge does not support any fundamental change in clinical practice with respect to the use of OCs, this book offers specific recommendations for more research to fully resolve the relationship between OCs and breast cancer. Noting consumer confusion, the volume includes a concise summary of benefits, risks, and other practical information for contraceptive users and their doctors. The volume presents current data on changes in patterns of OC use, differences in risk at different ages, the benefits of OCs, and more."--Website description | ||
| 650 | 4 | |a Breast Neoplasms / chemically induced | |
| 650 | 4 | |a Contraceptives, Oral / adverse effects | |
| 650 | 4 | |a Risk Factors | |
| 650 | 4 | |a Breast / Cancer / Epidemiology | |
| 650 | 4 | |a Oral contraceptives / Side effects | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 2 | |a Tumeurs du sein / induit chimiquement | |
| 650 | 2 | |a Contraceptifs oraux / effets indésirables | |
| 650 | 2 | |a Facteurs de risque | |
| 650 | 7 | |a Breast / Cancer / Epidemiology |2 fast | |
| 650 | 7 | |a Oral contraceptives / Side effects |2 fast | |
| 650 | 7 | |a Borstkanker |2 gtt | |
| 650 | 7 | |a Orale anticonceptiva |2 gtt | |
| 650 | 7 | |a Epidemiologie |2 gtt | |
| 650 | 7 | |a Risico's |2 gtt | |
| 650 | 7 | |a Ovulationshemmer |2 swd | |
| 650 | 7 | |a Brustkrebs |2 swd | |
| 650 | 7 | |a Arzneimittelnebenwirkung |2 swd | |
| 650 | 7 | |a Aufsatzsammlung |2 swd | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Breast |x Cancer |x Epidemiology |v Congresses | |
| 650 | 4 | |a Oral contraceptives |x Side effects |v Congresses | |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ovulationshemmer |0 (DE-588)4044229-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Ovulationshemmer |0 (DE-588)4044229-9 |D s |
| 689 | 0 | 1 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 2 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028494657 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175453250912256 |
|---|---|
| any_adam_object | |
| author_corporate | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer |
| author_corporate_role | aut |
| author_facet | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer |
| author_sort | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer |
| building | Verbundindex |
| bvnumber | BV043070465 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)43477116 (DE-599)BVBBV043070465 |
| dewey-full | 616.99/449071 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/449071 |
| dewey-search | 616.99/449071 |
| dewey-sort | 3616.99 6449071 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04204nmm a2200769zc 4500</leader><controlfield tag="001">BV043070465</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s1991 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309044936</subfield><subfield code="9">0-309-04493-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0585149011</subfield><subfield code="9">0-585-14901-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309044936</subfield><subfield code="9">978-0-309-04493-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780585149011</subfield><subfield code="9">978-0-585-14901-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)43477116</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043070465</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/449071</subfield><subfield code="2">20</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on the Relationship Between Oral Contraceptives and Breast Cancer</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oral contraceptives & breast cancer</subfield><subfield code="c">Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Oral contraceptives and breast cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academy Press</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (viii, 185 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"At least 10.7 million American women use oral contraceptives (OCs). The potential connection with breast cancer has caused concern among these OC users and uncertainty among many of their physicians. This new volume offers the most up-to-date information available on this critical topic. While the best available knowledge does not support any fundamental change in clinical practice with respect to the use of OCs, this book offers specific recommendations for more research to fully resolve the relationship between OCs and breast cancer. Noting consumer confusion, the volume includes a concise summary of benefits, risks, and other practical information for contraceptive users and their doctors. The volume presents current data on changes in patterns of OC use, differences in risk at different ages, the benefits of OCs, and more."--Website description</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms / chemically induced</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Contraceptives, Oral / adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Factors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast / Cancer / Epidemiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral contraceptives / Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Tumeurs du sein / induit chimiquement</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Contraceptifs oraux / effets indésirables</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Facteurs de risque</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast / Cancer / Epidemiology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oral contraceptives / Side effects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Borstkanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Orale anticonceptiva</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epidemiologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Risico's</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ovulationshemmer</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Epidemiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral contraceptives</subfield><subfield code="x">Side effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ovulationshemmer</subfield><subfield code="0">(DE-588)4044229-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Ovulationshemmer</subfield><subfield code="0">(DE-588)4044229-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028494657</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043070465 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:16:32Z |
| institution | BVB |
| isbn | 0309044936 0585149011 9780309044936 9780585149011 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028494657 |
| oclc_num | 43477116 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (viii, 185 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | National Academy Press |
| record_format | marc |
| spelling | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer Verfasser aut Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention Oral contraceptives and breast cancer Washington, D.C. National Academy Press 1991 1 Online-Ressource (viii, 185 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index "At least 10.7 million American women use oral contraceptives (OCs). The potential connection with breast cancer has caused concern among these OC users and uncertainty among many of their physicians. This new volume offers the most up-to-date information available on this critical topic. While the best available knowledge does not support any fundamental change in clinical practice with respect to the use of OCs, this book offers specific recommendations for more research to fully resolve the relationship between OCs and breast cancer. Noting consumer confusion, the volume includes a concise summary of benefits, risks, and other practical information for contraceptive users and their doctors. The volume presents current data on changes in patterns of OC use, differences in risk at different ages, the benefits of OCs, and more."--Website description Breast Neoplasms / chemically induced Contraceptives, Oral / adverse effects Risk Factors Breast / Cancer / Epidemiology Oral contraceptives / Side effects MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumeurs du sein / induit chimiquement Contraceptifs oraux / effets indésirables Facteurs de risque Breast / Cancer / Epidemiology fast Oral contraceptives / Side effects fast Borstkanker gtt Orale anticonceptiva gtt Epidemiologie gtt Risico's gtt Ovulationshemmer swd Brustkrebs swd Arzneimittelnebenwirkung swd Aufsatzsammlung swd Medizin Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Brustkrebs (DE-588)4008528-4 gnd rswk-swf Ovulationshemmer (DE-588)4044229-9 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Ovulationshemmer (DE-588)4044229-9 s Brustkrebs (DE-588)4008528-4 s Arzneimittelnebenwirkung (DE-588)4003134-2 s 1\p DE-604 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Oral contraceptives & breast cancer Breast Neoplasms / chemically induced Contraceptives, Oral / adverse effects Risk Factors Breast / Cancer / Epidemiology Oral contraceptives / Side effects MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumeurs du sein / induit chimiquement Contraceptifs oraux / effets indésirables Facteurs de risque Breast / Cancer / Epidemiology fast Oral contraceptives / Side effects fast Borstkanker gtt Orale anticonceptiva gtt Epidemiologie gtt Risico's gtt Ovulationshemmer swd Brustkrebs swd Arzneimittelnebenwirkung swd Aufsatzsammlung swd Medizin Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Brustkrebs (DE-588)4008528-4 gnd Ovulationshemmer (DE-588)4044229-9 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| subject_GND | (DE-588)4008528-4 (DE-588)4044229-9 (DE-588)4003134-2 (DE-588)1071861417 |
| title | Oral contraceptives & breast cancer |
| title_alt | Oral contraceptives and breast cancer |
| title_auth | Oral contraceptives & breast cancer |
| title_exact_search | Oral contraceptives & breast cancer |
| title_full | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
| title_fullStr | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
| title_full_unstemmed | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
| title_short | Oral contraceptives & breast cancer |
| title_sort | oral contraceptives breast cancer |
| topic | Breast Neoplasms / chemically induced Contraceptives, Oral / adverse effects Risk Factors Breast / Cancer / Epidemiology Oral contraceptives / Side effects MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumeurs du sein / induit chimiquement Contraceptifs oraux / effets indésirables Facteurs de risque Breast / Cancer / Epidemiology fast Oral contraceptives / Side effects fast Borstkanker gtt Orale anticonceptiva gtt Epidemiologie gtt Risico's gtt Ovulationshemmer swd Brustkrebs swd Arzneimittelnebenwirkung swd Aufsatzsammlung swd Medizin Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Brustkrebs (DE-588)4008528-4 gnd Ovulationshemmer (DE-588)4044229-9 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| topic_facet | Breast Neoplasms / chemically induced Contraceptives, Oral / adverse effects Risk Factors Breast / Cancer / Epidemiology Oral contraceptives / Side effects MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Tumeurs du sein / induit chimiquement Contraceptifs oraux / effets indésirables Facteurs de risque Borstkanker Orale anticonceptiva Epidemiologie Risico's Ovulationshemmer Brustkrebs Arzneimittelnebenwirkung Aufsatzsammlung Medizin Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=14485 |
| work_keys_str_mv | AT instituteofmedicineuscommitteeontherelationshipbetweenoralcontraceptivesandbreastcancer oralcontraceptivesbreastcancer AT instituteofmedicineuscommitteeontherelationshipbetweenoralcontraceptivesandbreastcancer oralcontraceptivesandbreastcancer |